Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data

Recent advances in the understanding of the pathophysiology of ulcerative colitis (UC) have led to the expansion of our therapeutic arsenal. Conventional treatment options, including aminosalicylates, corticosteroids, thiopurines, and calcineurin inhibitors, fail to control the disease in a signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Varyani, Fumi, Argyriou, Konstantinos, Phillips, Frank, Tsakiridou, Eirini, Moran, Gordon William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897052/
https://www.ncbi.nlm.nih.gov/pubmed/31819376
http://dx.doi.org/10.2147/DDDT.S182891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897052/
https://www.ncbi.nlm.nih.gov/pubmed/31819376
http://dx.doi.org/10.2147/DDDT.S182891

Ejemplares similares